Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
The results of a study on national drug trafficking laws and their application in the European Union. The penalties set out in national laws for trafficking are compared with the expected sentencing outcomes, including the estimated time to be spent in prison.
As high-purity/high-dose ecstasy pills return to the market and casualties rise, Oli Stevens discusses the roles testing can play. It can act as a harm reduction initiative, can it shape the composition of drug markets themselves?
This literature review examines the evidence of effectiveness of different types of drug prevention and education for children and young people in Scotland, principally that which is delivered in schools.
The study recommends: providing clear harm reduction guidance, ensuring that accurate information measuring GHB use and deaths is collected by relevant authorities, and guaranteeing that appropriate drug treatment services are accessible.
This study aims to provide evidence on international and EU approaches to drug policy, including emerging challenges and focusing on several case study countries. This evidence has been used to identify and develop policy proposals.
The EMCDDA met to discuss how the Council conclusions on the implementation of minimum quality standards in drug demand reduction in the EU can relate to projects at national, European and international level.
Scotland has witnessed a dramatic increase in overdose deaths and HIV infections among injecting drug users. in response, policy-makers in Glasgow are reported to be considering a proposal to open the first supervised injection site. David Liddell explains the current situation.
After success at a similar drug-checking project in festivals last summer, this pilot project will allow for the collection of evidence and evaluation of the effectiveness of such a scheme in UK nightclubs.
Prisons are in crisis with record levels of suicides, violence and self-harm. Spurred on by synthetic cannabinoids, 8% of men in prison in England and Wales report developing a drug problem since they have been in prison. In prisons with the worst regimes this is as high as 16%.
The International Conference on Medical Cannabis, held at the EU Parliament, aimed share knowledge about the state of legislation around the world today, and to educate regulators present about the importance of building legal, regulated cannabis markets in Europe.
Paris, France Palais des Congrès, 2 Place de la Porte Maillot, Paris
The program will serve as platform to showcase the current state of the HIV basic, clinical, social and implementation science fields and will offer interactive workshops, networking opportunities with leading researchers, and forums to share best practices and more.